Addus HomeCare [ADUS] vs Chemed [CHE] Detailed Stock Comparison

Addus HomeCare

NASDAQ
Loading...

Chemed

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Addus HomeCare wins in 5 metrics, Chemed wins in 14 metrics, with 0 ties. Chemed appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Addus HomeCare Chemed Better
P/E Ratio (TTM) 24.42 22.42 Chemed
Price-to-Book Ratio 1.97 5.28 Addus HomeCare
Debt-to-Equity Ratio 21.75 12.15 Chemed
PEG Ratio 1.23 -0.96 Chemed
EV/EBITDA 14.51 14.34 Chemed
Profit Margin (TTM) 6.51% 11.56% Chemed
Operating Margin (TTM) 9.41% 11.00% Chemed
EBITDA Margin (TTM) 9.41% 11.00% Chemed
Return on Equity 8.54% 24.14% Chemed
Return on Assets (TTM) 6.59% 13.56% Chemed
Free Cash Flow (TTM) $110.38M $367.97M Chemed
Dividend Yield N/A 0.18% N/A
1-Year Return -12.44% -26.86% Addus HomeCare
Price-to-Sales Ratio (TTM) 1.60 2.53 Addus HomeCare
Enterprise Value $2.14B $6.23B Chemed
EV/Revenue Ratio 1.68 2.48 Addus HomeCare
Gross Profit Margin (TTM) 32.59% 29.85% Addus HomeCare
Revenue per Share (TTM) $71 $170 Chemed
Earnings per Share (Diluted) $4.53 $19.45 Chemed
Beta (Stock Volatility) 0.86 0.43 Chemed
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Addus HomeCare vs Chemed Stock Performance Analysis

Loading Price Chart...

Addus HomeCare
Chemed
Addus HomeCare Stock Overview | Chemed Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Addus HomeCare-1.29%-0.93%1.18%-0.03%13.25%-7.95%
Chemed-0.32%-2.40%-6.77%-8.52%-26.64%-18.29%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Addus HomeCare-12.44%11.86%11.56%237.90%3,033.70%1,150.05%
Chemed-26.86%-0.25%-13.34%227.74%644.32%952.22%

News Based Sentiment: Addus HomeCare vs Chemed

Addus HomeCare

News based Sentiment: POSITIVE

The month of October saw a wave of positive analyst ratings and price target increases for Addus HomeCare, coupled with strong institutional investment and promising growth projections. While risks related to labor and healthcare funding exist, the overall narrative is one of continued optimism and potential upside for investors.

View Addus HomeCare News Sentiment Analysis

Chemed

News based Sentiment: MIXED

Chemed experienced a month of mixed signals, with a recent earnings miss and insider selling offset by strategic initiatives and a commitment to shareholder returns. The upcoming Q3 earnings release is a critical catalyst for the stock's future, making this a significant month for investors to assess the company's direction.

View Chemed News Sentiment Analysis

Performance & Financial Health Analysis: Addus HomeCare vs Chemed

MetricADUSCHE
Market Information
Market Cap i$2.04B$6.35B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i142,820198,980
90 Day Avg. Volume i142,563201,887
Last Close$112.91$430.02
52 Week Range$88.96 - $136.72$408.42 - $623.61
% from 52W High-17.42%-31.04%
All-Time High$136.72 (Jan 20, 2025)$654.62 (Mar 11, 2024)
% from All-Time High-17.42%-34.31%
Growth Metrics
Quarterly Revenue Growth0.22%0.04%
Quarterly Earnings Growth0.22%-0.26%
Financial Health
Profit Margin (TTM) i0.07%0.12%
Operating Margin (TTM) i0.09%0.11%
Return on Equity (TTM) i0.09%0.24%
Debt to Equity (MRQ) i21.7512.15
Cash & Liquidity
Book Value per Share (MRQ)$56.26$82.56
Cash per Share (MRQ)$5.02$17.22
Operating Cash Flow (TTM) i$100.42M$426.78M
Levered Free Cash Flow (TTM) i$50.85M$285.06M
Dividends
Last 12-Month Dividend Yield iN/A0.18%
Last 12-Month Dividend iN/A$1.00

Valuation & Enterprise Metrics Analysis: Addus HomeCare vs Chemed

MetricADUSCHE
Price Ratios
P/E Ratio (TTM) i24.4222.42
Forward P/E i19.0117.52
PEG Ratio i1.23-0.96
Price to Sales (TTM) i1.602.53
Price to Book (MRQ) i1.975.28
Market Capitalization
Market Capitalization i$2.04B$6.35B
Enterprise Value i$2.14B$6.23B
Enterprise Value Metrics
Enterprise to Revenue i1.682.48
Enterprise to EBITDA i14.5114.34
Risk & Other Metrics
Beta i0.860.43
Book Value per Share (MRQ) i$56.26$82.56

Financial Statements Comparison: Addus HomeCare vs Chemed

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)ADUSCHE
Revenue/Sales i$349.44M$646.94M
Cost of Goods Sold i$235.57M$430.53M
Gross Profit i$113.88M$216.41M
Research & Development iN/AN/A
Operating Income (EBIT) i$32.89M$94.76M
EBITDA i$37.38M$112.02M
Pre-Tax Income i$29.95M$95.67M
Income Tax i$7.89M$23.92M
Net Income (Profit) i$22.05M$71.76M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)ADUSCHE
Cash & Equivalents i$96.95M$173.88M
Total Current Assets i$257.83M$502.39M
Total Current Liabilities i$147.94M$290.56M
Long-Term Debt i$238.15M$102.08M
Total Shareholders Equity i$995.38M$1.18B
Retained Earnings i$397.66M$2.79B
Property, Plant & Equipment i$69.77M$724.13M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)ADUSCHE
Operating Cash Flow i$16.26M$34.75M
Capital Expenditures i$-1.88M$112,000
Free Cash Flow i$17.07M$19.46M
Debt Repayment i$-20.00MN/A
Common Stock Repurchase iN/A$-33.22M

Short Interest & Institutional Ownership Analysis

MetricADUSCHE
Shares Short i623,550387,671
Short Ratio i5.082.17
Short % of Float i0.04%0.03%
Average Daily Volume (10 Day) i142,820198,980
Average Daily Volume (90 Day) i142,563201,887
Shares Outstanding i18.15M14.56M
Float Shares i17.32M14.29M
% Held by Insiders i0.03%0.02%
% Held by Institutions i1.10%0.98%

Dividend Analysis & Yield Comparison: Addus HomeCare vs Chemed

MetricADUSCHE
Last 12-Month Dividend iN/A$1.00
Last 12-Month Dividend Yield iN/A0.18%
3-Year Avg Annual Dividend iN/A$1.37
3-Year Avg Dividend Yield iN/A0.08%
3-Year Total Dividends iN/A$4.10
Ex-Dividend DateN/ANov 18, 2024